Works matching AU Lambert, Karoline A.

Results: 7

SASH1 Is Involved in an Autosomal Dominant Lentiginous Phenotype.

Published in:

Journal of Investigative Dermatology, 2015, v. 135, n. 12, p. 3192, doi. 10.1038/jid.2015.292

By:

Shellman, Yiqun G;
Lambert, Karoline A;
Brauweiler, Anne;
Fain, Pamela;
Spritz, Richard A;
Martini, Melanie;
Janssen, Klaus-Peter;
Box, Neil F;
Terzian, Tamara;
Rewers, Marian;
Horvath, Anelia;
Stratakis, Constantine A;
Robinson, William A;
Robinson, Steven E;
Norris, David A;
Artinger, Kristin B;
Pacheco, Theresa R

Publication type:

Article

Combining a BCL2 Inhibitor with the Retinoid Derivative Fenretinide Targets Melanoma Cells Including Melanoma Initiating Cells.

Published in:

Journal of Investigative Dermatology, 2015, v. 135, n. 3, p. 842, doi. 10.1038/jid.2014.464

By:

Mukherjee, Nabanita;
Reuland, Steven N;
Lu, Yan;
Luo, Yuchun;
Lambert, Karoline;
Fujita, Mayumi;
Robinson, William A;
Robinson, Steven E;
Norris, David A;
Shellman, Yiqun G

Publication type:

Article

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.

Published in:

Cancers, 2020, v. 12, n. 8, p. 2182, doi. 10.3390/cancers12082182

By:

Mukherjee, Nabanita;
Amato, Carol M.;
Skees, Jenette;
Todd, Kaleb J.;
Lambert, Karoline A.;
Robinson, William A.;
Van Gulick, Robert;
Weight, Ryan M.;
Dart, Chiara R.;
Tobin, Richard P.;
McCarter, Martin D.;
Fujita, Mayumi;
Norris, David A.;
Shellman, Yiqun G.

Publication type:

Article

Loss of prdm1a accelerates melanoma onset and progression.

Published in:

Molecular Carcinogenesis, 2020, v. 59, n. 9, p. 1052, doi. 10.1002/mc.23236

By:

Iwanaga, Ritsuko;
Truong, Brittany T.;
Hsu, Jessica Y.;
Lambert, Karoline A.;
Vyas, Rajesh;
Orlicky, David;
Shellman, Yiqun G.;
Tan, Aik‐Choon;
Ceol, Craig;
Artinger, Kristin Bruk

Publication type:

Article

MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade.

Published in:

Cell Death & Disease, 2024, v. 15, n. 3, p. 1, doi. 10.1038/s41419-024-06524-w

By:

Mukherjee, Nabanita;
Katsnelson, Elizabeth;
Brunetti, Tonya M.;
Michel, Kylie;
Couts, Kasey L.;
Lambert, Karoline A.;
Robinson, William A.;
McCarter, Martin D.;
Norris, David A.;
Tobin, Richard P.;
Shellman, Yiqun G.

Publication type:

Article

MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells.

Published in:

Cell Death & Disease, 2020, v. 11, n. 6, p. 1, doi. 10.1038/s41419-020-2646-2

By:

Mukherjee, Nabanita;
Skees, Jenette;
Todd, Kaleb J.;
West, Drake A.;
Lambert, Karoline A.;
Robinson, William A.;
Amato, Carol M.;
Couts, Kasey L.;
Van Gulick, Robert;
MacBeth, Morgan;
Nassar, Kelsey;
Tan, Aik-Choon;
Zhai, Zili;
Fujita, Mayumi;
Bagby, Stacey M.;
Dart, Chiara R.;
Lambert, James R.;
Norris, David A.;
Shellman, Yiqun G.

Publication type:

Article

BH3 mimetics induce apoptosis independent of DRP-1 in melanoma.

Published in:

Cell Death & Disease, 2018, v. 9, n. 9, p. 1, doi. 10.1038/s41419-018-0932-z

By:

Mukherjee, Nabanita;
Strosnider, Andrew;
Vagher, Bay;
Lambert, Karoline A.;
Slaven, Sarah;
Robinson, William A.;
Amato, Carol M.;
Couts, Kasey L.;
Bemis, Judson G. T.;
Turner, Jacqueline A.;
Norris, David A.;
Shellman, Yiqun G.

Publication type:

Article